H.P. 383 - L.D. 499
Sec. TT-1. 22 MRSA §851, as enacted by PL 1999, c. 731, Pt. SS, §1, is amended to read:
1. Creation of fund.
The Human Leukocyte Antigen Bone Marrow Screening Fund, referred to in this section as the "fund," is established as a nonlapsing fund to support bone marrow screening by individuals and organizations determined to be eligible according to rules adopted by the department under subsection 2. Money in the fund must be expended as allocated by the Legislature for the purposes of the fund and may be invested as provided by law. Interest on these investments must be credited to the fund.
The department shall administer the fund and shall adopt rules as necessary to administer the fund and to determine the criteria for eligible recipients. Rules adopted pursuant to this section are routine technical rules as defined in Title 5, chapter 375, subchapter II-A 2-A.
3. Income tax checkoff funding.
Revenue collected from the income tax checkoff pursuant to Title 36, section 5285-A must be credited to the fund.
4. Other funds.
The fund may receive money from any source, including grants, gifts, bequests and donations.
Sec. TT-2. 36 MRSA §5285-A, as enacted by PL 1999, c. 731, Pt. SS, §2, is amended to read:
1. Bone Marrow Screening Fund.
When filing a return, a taxpayer entitled to a refund under this Part may designate that a portion of that refund be paid into the Human Leukocyte Antigen Bone Marrow Screening Fund established in Title 22, chapter 250-A. A taxpayer who is not entitled to a refund under this Part may contribute to the Human Leukocyte Antigen Bone Marrow Screening Fund by including with that taxpayer's return sufficient funds to make the contribution. Each individual income tax return form must contain a designation in substantially the following form: " Human Leukocyte Antigen Bone Marrow Screening Fund: ( ) $5, ( ) $10, ( ) $25 or ( ) Other $ ."
2. Contributions credited to the Bone Marrow Screening Fund.
The State Tax Assessor shall determine annually the total amount contributed pursuant to subsection 1. Prior to the beginning of the next year, the State Tax Assessor shall deduct the cost of administering the Human Leukocyte Antigen Bone Marrow Screening Fund checkoff, but not exceeding $2,000 annually, and report the remainder to the Treasurer of State, who shall forward that amount to the Human Leukocyte Antigen Bone Marrow Screening Fund.
3. Effective date.
This section applies to tax years beginning on and after January 1, 2000.
Sec. TT-3. Application date. That section of this Part that amends the Maine Revised Statutes, Title 36, section 5285-A applies to tax years beginning on or after January 1, 2007.
Sec. TT-4. Rename the Human Leukocyte Antigen Screening Fund and Fund for a Healthy Maine - Human Leukocyte program. The "Human Leukocyte Antigen Screening Fund" is renamed the "Bone Marrow Screening Fund" and the "Fund for a Healthy Maine - Human Leukocyte" program is renamed the "Fund for a Healthy Maine - Bone Marrow Screening" program.